{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:16:27Z","timestamp":1789600587069,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,6,15]],"date-time":"2007-06-15T00:00:00Z","timestamp":1181865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,11,21]]},"DOI":"10.1007\/s10067-007-0656-4","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T12:50:43Z","timestamp":1181825443000},"page":"77-83","source":"Crossref","is-referenced-by-count":78,"title":["A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis"],"prefix":"10.1007","volume":"27","author":[{"given":"Mittermayer","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomitsu","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abu-Hakima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P.","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Taillefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Khraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Markland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,15]]},"reference":[{"key":"656_CR1","first-page":"2513","volume":"29","author":"HE Paulus","year":"2002","unstructured":"Paulus HE, Wiesner J, Bulpitt KJ, et al (2002) Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment. J Rheumatol 29:2513\u20132520","journal-title":"J Rheumatol"},{"key":"656_CR2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, Lee J, McCoy A, et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236\u2013243","journal-title":"Arthritis Res"},{"key":"656_CR3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"VPK Nell","year":"2005","unstructured":"Nell VPK, Machold KP, Stamm TA, et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731\u20131736","journal-title":"Ann Rheum Dis"},{"key":"656_CR4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845\u2013851","journal-title":"Ann Rheum Dis"},{"key":"656_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","volume":"45","author":"AJ Zendman","year":"2006","unstructured":"Zendman AJ, Van Venrooij WJ, Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 45:20\u201325","journal-title":"Rheumatology (Oxford)"},{"key":"656_CR6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ncprheum0401","volume":"3","author":"HA Menard","year":"2007","unstructured":"Menard HA (2007) Anti-CCP versus anti-Sa antibodies for the diagnosis of RA. Nat Clin Pract Rheumatol 3:76\u201377","journal-title":"Nat Clin Pract Rheumatol"},{"key":"656_CR7","first-page":"1257","volume":"60","author":"PJ Scheuer","year":"1967","unstructured":"Scheuer PJ (1967) Primary biliary cirrhosis. Proc R Soc Med 60:1257\u20131260","journal-title":"Proc R Soc Med"},{"key":"656_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0025-6196(11)63652-5","volume":"73","author":"PJ Scheuer","year":"1988","unstructured":"Scheuer PJ (1988) Ludwig Symposium on biliary disorders\u2014part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc 73:179\u2013183","journal-title":"Mayo Clin Proc"},{"key":"656_CR9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2249.2004.02456.x","volume":"136","author":"K Miyachi","year":"2004","unstructured":"Miyachi K, Hirano Y, Horigome T, et al (2004) Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97\/VCP and inhibit in vitro nuclear envelope assembly. Clin Exp Immunol 136:568\u2013573","journal-title":"Clin Exp Immunol"},{"key":"656_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","volume":"20","author":"K Miyachi","year":"2003","unstructured":"Miyachi K, Hankins RW, Matsushima H, et al (2003) Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 20:247\u2013254","journal-title":"J Autoimmun"},{"key":"656_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"656_CR12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jcla.1860090312","volume":"9","author":"MJ Fritzler","year":"1995","unstructured":"Fritzler MJ, Miller BJ (1995) Detection of autoantibodies to SS-A\/Ro by indirect immunofluorescence using a transfected and overexpressed human 60\u00a0kD Ro autoantigen in HEp-2 cells. J Clin Lab Anal 9:218\u2013224","journal-title":"J Clin Lab Anal"},{"key":"656_CR13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2249.2000.01390.x","volume":"122","author":"S Selak","year":"2000","unstructured":"Selak S, Woodman RC, Fritzler MJ (2000) Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA). Clin Exp Immunol 122:493\u2013498","journal-title":"Clin Exp Immunol"},{"key":"656_CR14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00109-003-0495-y","volume":"81","author":"T Eystathioy","year":"2003","unstructured":"Eystathioy T, Chan EKL, Yang Z, et al (2003) Clinical and serological associations of autoantibodies to a novel cytoplasmic autoantigen, GW182 and GW bodies. J Mol Med 81:811\u2013818","journal-title":"J Mol Med"},{"key":"656_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118\u2013127","journal-title":"Hepatology"},{"key":"656_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.1780270114","volume":"27","author":"MJ Fritzler","year":"1984","unstructured":"Fritzler MJ, Valencia DW, McCarty GA (1984) Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum 27:92\u201396","journal-title":"Arthritis Rheum"},{"key":"656_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jcla.10026","volume":"16","author":"MJ Fritzler","year":"2002","unstructured":"Fritzler MJ, Hanson C, Miller J, Eystathioy T (2002) Specificity of autoantibodies to SS-A\/Ro on a transfected and overexpressed human 60\u00a0kDa Ro autoantigen substrate. J Clin Lab Anal 16:103\u2013108","journal-title":"J Clin Lab Anal"},{"key":"656_CR18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10067-006-0313-3","volume":"26","author":"F Ingegnoli","year":"2006","unstructured":"Ingegnoli F, Galbiati V, Zeni S, et al (2006) Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26:510\u2013514","journal-title":"Clin Rheumatol"},{"key":"656_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1529-1049(02)00058-2","volume":"3","author":"MJ Fritzler","year":"2002","unstructured":"Fritzler MJ, Manns MP (2002) Anti-mitochondrial antibodies. Clin Appl Immunol Rev 3:87\u2013113","journal-title":"Clin Appl Immunol Rev"},{"key":"656_CR20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF02238555","volume":"15","author":"M Fusconi","year":"1996","unstructured":"Fusconi M, Berti CC, Monti G, et al (1996) Antikeratin antibodies (AKA) negativity in primary biliary cirrhosis (PBC): confirmation of their specificity in the diagnosis of rheumatoid arthritis (RA). Clin Rheumatol 15:617\u2013618","journal-title":"Clin Rheumatol"},{"key":"656_CR21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2036.2005.02686.x","volume":"22","author":"M Fusconi","year":"2005","unstructured":"Fusconi M, Vannini A, Dall\u2019Aglio AC, et al (2005) Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis. Aliment Pharmacol Ther 22:951\u2013955","journal-title":"Aliment Pharmacol Ther"},{"key":"656_CR22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780260714","volume":"26","author":"D Makinen","year":"1983","unstructured":"Makinen D, Fritzler MJ, Davis P, Sherlock S (1983) Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 26:914\u2013917","journal-title":"Arthritis Rheum"},{"key":"656_CR23","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar1041","volume":"6","author":"M Bombardieri","year":"2004","unstructured":"Bombardieri M, Alessandri C, Labbadia G, et al (2004) Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 6:R137\u2013R141","journal-title":"Arthritis Res Ther"},{"key":"656_CR24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","volume":"50","author":"MH Wener","year":"2004","unstructured":"Wener MH, Hutchinson K, Morishima C, Gretch DR (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50:2305\u20132308","journal-title":"Arthritis Rheum"},{"key":"656_CR25","first-page":"2390","volume":"33","author":"T Matsui","year":"2006","unstructured":"Matsui T, Shimada K, Ozawa N, et al (2006) Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 33:2390\u20132397","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0656-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0656-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:08Z","timestamp":1559119868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11,21]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0656-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,15]]}}}